News
On late night TV and across the Internet, swine flu (officially re-branded the 'H1N1 flu,' a name change about as likely to stick as Prince's multi-symbol moniker) has turned into a punchline.
You know it's cold and flu season when the giant pallet of Costco tissue has disappeared. Trips to the doctor, lost work time, bills for pharmaceuticals and snot everywhere makes sick season an ...
FluMist vaccine vs. flu shot The FluMist vaccine, manufactured by AstraZeneca, was approved in 2003 for health care providers to give patients, but the method has gotten renewed attention due to a ...
At the postponed meeting, the panel was scheduled to discuss a new meningitis vaccine, a shot targeting the mosquito-borne Chikungunya virus, along with RSV and influenza shots. Big Number 19,000.
Doctors have an urgent warning about flu season. Nationwide, flu cases are 13 times higher than around this time last year. Health experts say it's largely because protective measures to stop ...
Most Americans will be eligible for both the new monovalent Covid vaccine and the annual flu shot this fall. You can schedule your vaccines separately or choose to get them at the same time.
Moderna said Wednesday that its experimental mRNA-based seasonal flu vaccine generated a stronger immune response against four strains of the flu virus than a currently marketed vaccine in a Phase ...
Moderna Inc. said it has “voluntarily” withdrawn its application for regulatory approval for its combination COVID and flu shot for people 50 and over, a setback for the company.
Of the participants, 43,857 were vaccinated during the study period with 98.7 percent receiving the inactivated trivalent influenza vaccine. By the study’s end, 1,079 participants had gotten the ...
Moderna's cost-cutting drives better-than-expected results Combination COVID and flu shot approval not expected until 2026 Tariffs have minimal impact on Moderna's U.S.-manufactured drugs May 1 ...
It's been a training camp to remember for Atlanta Falcons coach Arthur Smith at the podium - and he added another quality line to the list during Monday's press conference.
Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine candidate to wait for efficacy data from a late-stage trial of its influenza ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results